Updated on 16 September 2026
ELEMENTARY - compounds validation
Associate Researcher at Istituto Auxologico Italiano
Milan, Italy
About
We offer access to a patient-derived preclinical screening platform for rare endocrine tumors (currently under validation for medullary thyroid carcinoma and neuroendocrine tumors). We are seeking partners wishing to test compounds, including approved drugs, repurposed molecules, or novel candidates, on clinically representative tumor models in an exploratory, research-collaboration framework.
Similar opportunities
Investment
ELEMENTARy - funding opportunities
- Pre-seed funding | Idea validation
Elisa Stellaria Grassi
Associate Researcher at Istituto Auxologico Italiano
Milan, Italy
Product
Elisa Stellaria Grassi
Associate Researcher at Istituto Auxologico Italiano
Milan, Italy
Investment
iRASP - a novel platform to design efficacious cancer targeted immunotherapies
- Pre-seed funding | Idea validation
- Seed funding | Get business started
Giorgia Moschetti
IP & Technology Transfer Specialist at Istituto Europeo di Oncologia (IEO)
Milan, Italy